108 related articles for article (PubMed ID: 24572114)
1. [Interleukin-7, a new immunoadjuvant for the treatment of septic shock].
Monneret G; Villars-Méchin A; Demaret J; Foray AP; Venet F
Med Sci (Paris); 2014 Feb; 30(2):160-5. PubMed ID: 24572114
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.
Francois B; Jeannet R; Daix T; Walton AH; Shotwell MS; Unsinger J; Monneret G; Rimmelé T; Blood T; Morre M; Gregoire A; Mayo GA; Blood J; Durum SK; Sherwood ER; Hotchkiss RS
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515037
[TBL] [Abstract][Full Text] [Related]
3. STAT5 phosphorylation in T cell subsets from septic patients in response to recombinant human interleukin-7: a pilot study.
Demaret J; Dupont G; Venet F; Friggeri A; Lepape A; Rimmelé T; Morel J; Monneret G
J Leukoc Biol; 2015 Apr; 97(4):791-6. PubMed ID: 25691382
[TBL] [Abstract][Full Text] [Related]
4. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers.
Ono S; Kimura A; Hiraki S; Takahata R; Tsujimoto H; Kinoshita M; Miyazaki H; Yamamoto J; Hase K; Saitoh D
Surgery; 2013 Feb; 153(2):262-71. PubMed ID: 22884251
[TBL] [Abstract][Full Text] [Related]
5. IL-7 Restores T Lymphocyte Immunometabolic Failure in Septic Shock Patients through mTOR Activation.
Venet F; Demaret J; Blaise BJ; Rouget C; Girardot T; Idealisoa E; Rimmelé T; Mallet F; Lepape A; Textoris J; Monneret G
J Immunol; 2017 Sep; 199(5):1606-1615. PubMed ID: 28724580
[TBL] [Abstract][Full Text] [Related]
6. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis.
Monneret G; Debard AL; Venet F; Bohe J; Hequet O; Bienvenu J; Lepape A
Crit Care Med; 2003 Jul; 31(7):2068-71. PubMed ID: 12847405
[TBL] [Abstract][Full Text] [Related]
7. Harnessing the biology of IL-7 for therapeutic application.
Mackall CL; Fry TJ; Gress RE
Nat Rev Immunol; 2011 May; 11(5):330-42. PubMed ID: 21508983
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?
Leentjens J; Kox M; van der Hoeven JG; Netea MG; Pickkers P
Am J Respir Crit Care Med; 2013 Jun; 187(12):1287-93. PubMed ID: 23590272
[TBL] [Abstract][Full Text] [Related]
9. Septic shock: new pharmacotherapy options or better trial design?
Vincent JL; Van Nuffelen M
Expert Opin Pharmacother; 2013 Apr; 14(5):561-70. PubMed ID: 23452102
[TBL] [Abstract][Full Text] [Related]
10. Decreased T-cell repertoire diversity in sepsis: a preliminary study.
Venet F; Filipe-Santos O; Lepape A; Malcus C; Poitevin-Later F; Grives A; Plantier N; Pasqual N; Monneret G
Crit Care Med; 2013 Jan; 41(1):111-9. PubMed ID: 23222261
[TBL] [Abstract][Full Text] [Related]
11. First experience with immunomodulation in septic shock.
Josten C; Muhr G; Sistermann R
Prog Clin Biol Res; 1989; 308():989-94. PubMed ID: 2528747
[No Abstract] [Full Text] [Related]
12. The involvement of tumor necrosis factor-alpha (TNF-alpha) in immunomodulation and in septic shock.
Espevik T; Waage A
Dev Biol Stand; 1988; 69():139-42. PubMed ID: 3265675
[No Abstract] [Full Text] [Related]
13. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
Theze J
Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
[TBL] [Abstract][Full Text] [Related]
14. The role of naïve T-cells in HIV-1 pathogenesis: an emerging key player.
Khoury G; Rajasuriar R; Cameron PU; Lewin SR
Clin Immunol; 2011 Dec; 141(3):253-67. PubMed ID: 21996455
[TBL] [Abstract][Full Text] [Related]
15. Treatment of septic shock with immunotherapy.
Smith AL
Pharmacotherapy; 1998; 18(3):565-80. PubMed ID: 9620107
[TBL] [Abstract][Full Text] [Related]
16. Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy.
Monneret G; Venet F
Cytometry B Clin Cytom; 2016 Jul; 90(4):376-86. PubMed ID: 26130241
[TBL] [Abstract][Full Text] [Related]
17. Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury.
Lee SY; Lee YS; Choi HM; Ko YS; Lee HY; Jo SK; Cho WY; Kim HK
Crit Care Med; 2012 Nov; 40(11):2997-3006. PubMed ID: 22878677
[TBL] [Abstract][Full Text] [Related]
18. The pathophysiology of septic shock.
Nduka OO; Parrillo JE
Crit Care Clin; 2009 Oct; 25(4):677-702, vii. PubMed ID: 19892247
[TBL] [Abstract][Full Text] [Related]
19. HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis.
Marchetti G; Riva A; Cesari M; Bellistrì GM; Gianelli E; Casabianca A; Orlandi C; Magnani M; Meroni L; d'Arminio Monforte A; Mussini C; Cossarizza A; Galli M; Gori A;
HIV Med; 2009 Aug; 10(7):422-31. PubMed ID: 19459995
[TBL] [Abstract][Full Text] [Related]
20. What is the pathophysiology of the septic host upon admission?
Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S2-5. PubMed ID: 21129934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
